Perseon Cancer Ablation Therapy Expanded To Treat Liver Tumors
This article was originally published in The Gray Sheet
Executive Summary
The newly renamed company says FDA has cleared its MicroThermX microwave ablation system to treat complicated non-resectable liver tumors.
You may also be interested in...
People Briefs: BSD Medical CEO; TransEnterix COO Resigns; Delphinus Medical
Device industry veteran Clint Carnell named president and CEO of BSD Medical; TransEnterix reports resignation of chief operating officer; Delphinus Medical Technologies appoints VP, finance.
New Products In Brief
Abbott earns approval in Japan for Xience Xpedition everolimus-eluting stent. Zimmer will distribute SpineCraft’s APEX system. More new product news.
New Products In Brief
Bausch & Lomb's Stellaris PC: Company debuts its Stellaris PC (Procedural Choice) vision enhancement system overseas following CE mark approval last May. The combined vitrectomy and phacoemulsification system, for which a May 510(k) submission remains pending at FDA, enhances surgeons' ability to see ocular tissue under various surgical conditions, B&L claims. Stellaris PC is indicated for emulsification and removal of cataracts, and anterior and posterior segment vitrectomy